Tina Marie Devries

US Patent:

6521247, Feb 18, 2003

Filed:

Mar 31, 2000

Appl. No.:

09/539360

Inventors:

Tina deVries - Long Valley NJ

Assignee:

Warner Chilcott Laboratories Ireland Limited - Rockaway NJ

International Classification:

A61K 4700

US Classification:

424439, 424441, 424451, 424452, 424457, 424464, 424465, 424468, 424489, 426 73, 426 74, 514276, 514251

Abstract:

The present invention relates to a nutritional supplement which comprises two different iron compounds, namely a rapidly dissolving iron compound and a slowly dissolving iron compound. The tablet is particularly contemplated for administration to women as a prenatal supplement, during pregnancy, and during lactation. Methods of alleviating iron deficiency and diseases and disorders associated therewith are also disclosed.

US Patent:

6667050, Dec 23, 2003

Filed:

Jun 12, 2001

Appl. No.:

09/879028

Inventors:

Roger M. Boissonneault - Long Valley NJ
Tina M. deVries - Long Valley NJ

Assignee:

Galen (Chemicals) Limited - Dunlaoghaire

International Classification:

A61K 4700

US Classification:

424439, 424400, 424440, 424441, 424464, 424484, 424489, 514841, 514843

Abstract:

The present invention relates to a chewable, palatable oral contraceptive tablet, comprising an oral contraceptive agent, a chewable carrier suitable for human consumption, and not comprising a ferrocene compound, as well as use of these tablets in a method of human female oral contraception, and in a method of enhancing compliance with a human female oral contraceptive regimen.

US Patent:

6962908, Nov 8, 2005

Filed:

Dec 21, 2001

Appl. No.:

10/023748

Inventors:

Oluwole T. Aloba - Morristown NJ, US
Tina M. deVries - Long Valley NJ, US

Assignee:

Warner Chilcott Company Inc. - Fajardo PR

International Classification:

A61K031/56
A01N025/08

US Classification:

514170, 514178, 424409

Abstract:

A pharmaceutical dosage unit for oral administration to a human female comprising a therapeutically effective amount of 17β-estradiol-3-lower alkanoate, most preferably 17β-estradiol-3-acetate, and a pharmaceutically acceptable carrier is disclosed. Also disclosed is a method for treating a human female in need of 17β-estradiol and a contraceptive method by oral administration of the pharmaceutical dosage unit and a method of preparing a pharmaceutical composition that may be used to form the pharmaceutical dosage unit of the invention.

US Patent:

7485319, Feb 3, 2009

Filed:

Jul 22, 2004

Appl. No.:

10/896045

Inventors:

Tina deVries - Long Valley NJ, US
Lynn Gold - Seattle WA, US

Assignee:

Warner Chilcott Company, Inc. - Fajardo PR

International Classification:

A61K 9/14
A61K 9/20
A61K 9/28

US Classification:

424441, 424464, 424465, 424489

Abstract:

The present invention is a solid dosage form of a doxycycline metal complex. The present invention also includes a process for making a doxycycline metal complex in a solid dosage form. The process comprises the steps of (i) providing an aqueous solution of doxycycline or a physiologically acceptable salt thereof; (ii) admixing a metal salt with the aqueous solution; (iii) admixing a base to increase the pH of the aqueous solution, thereby forming a suspension of doxycycline metal; and (iv) drying the suspension, thereby forming a dry granulation of doxycycline metal complex.

US Patent:

7572779, Aug 11, 2009

Filed:

Apr 29, 2004

Appl. No.:

10/833997

Inventors:

Oluwole T. Aloba - Morristown NJ, US
Tina M deVries - Long Valley NJ, US

Assignee:

Warner Chilcott Company LLC - Fajardo PR

International Classification:

A61K 31/56
A01N 25/08

US Classification:

514170, 514178, 514171, 514182, 424409

Abstract:

A pharmaceutical dosage unit for oral administration to a human female comprising a therapeutically effective amount of 17β-estradiol-3-lower alkanoate, most preferably 17β-estradiol-3-acetate, and a pharmaceutically acceptable carrier is disclosed. Also disclosed is a method for treating a human female in need of 17β-estradiol and a contraceptive method by oral administration of the pharmaceutical dosage unit and a method of preparing a pharmaceutical composition that may be used to form the pharmaceutical dosage unit of the invention.

US Patent:

7799771, Sep 21, 2010

Filed:

Jun 17, 2005

Appl. No.:

11/154704

Inventors:

Oluwole T. Aloba - Morristown NJ, US
Tina M. deVries - Long Valley NJ, US

Assignee:

Warner Chilcott Company, LLC. - Fajardo PR

International Classification:

A61K 31/56
A01N 25/08

US Classification:

514182, 514170, 514178, 424409

Abstract:

A pharmaceutical dosage unit for oral administration to a human female comprising a therapeutically effective amount of 17β-estradiol-3-lower alkanoate, most preferably 17β-estradiol-3-acetate, and a pharmaceutically acceptable carrier is disclosed. Also disclosed is a method for treating a human female in need of 17β-estradiol and a contraceptive method by oral administration of the pharmaceutical dosage unit and a method of preparing a pharmaceutical composition that may be used to form the pharmaceutical dosage unit of the invention.

US Patent:

8415331, Apr 9, 2013

Filed:

Dec 18, 2008

Appl. No.:

12/338491

Inventors:

Tina deVries - Long Valley NJ, US
Lynn Gold - Seattle WA, US

Assignee:

Warner Chilcott Company, LLC - Fajardo PR

International Classification:

A61K 31/65
A61K 9/48
A61K 9/20

US Classification:

514152, 424451, 424464

Abstract:

The present invention is a solid dosage form of a doxycycline metal complex. The present invention also includes a process for making a doxycycline metal complex in a solid dosage form. The process comprises the steps of (i) providing an aqueous solution of doxycycline or a physiologically acceptable salt thereof; (ii) admixing a metal salt with the aqueous solution; (iii) admixing a base to increase the pH of the aqueous solution, thereby forming a suspension of doxycycline metal; and (iv) drying the suspension, thereby forming a dry granulation of doxycycline metal complex.

US Patent:

20050038005, Feb 17, 2005

Filed:

Apr 7, 2004

Appl. No.:

10/819764

Inventors:

Roger Boissonneault - Long Valley NJ, US
Tina deVries - Long Valley NJ, US
Herman Ellman - Boonton Township NJ, US
Kathryn MacFarlane - Morristown NJ, US
Kelly Smith - Mountain Lakes NJ, US

International Classification:

A61K031/56

US Classification:

514170000

Abstract:

The present invention is a method of non-continuous administration of a pharmaceutical to a female for a condition associated with the female's menstrual cycle, comprising ascertaining a number of days in the female's menstrual cycle, and then administering a daily first dosage, starting on the first or the second day of the menstrual cycle and continuing the daily administration for a first dosage period. Next administering a daily second dosage, starting on the day after the last daily first dosage was administered and continuing the daily administration of the second dosage for a second dosage period. Wherein either the first dosage is a placebo and the second dosage is the pharmaceutical, or the first dosage is the pharmaceutical and the second dosage is a placebo. Both the first dosages and the second dosages being contained in a single package.